Bionik Laboratories Corp. (BNKL)

[trendmkr]

FDA approval eyed
Top-line data from clinical testing should hit markets during the second half of next year. From there, and assuming the tech gets the thumbs up from one or all of the FDA, the EMA and Canada Health, Bionik expects to start shipping to health centers initially in Canada. We are looking at the second quarter 2017 as a target for this development. Once commercialization commences, Bionik expects to file for an uplisting, which should draw some level of institutional attention as the company ceases to be over the counter.